Yeah I agree overall our results are top of the class but it's just typical shitco behaviour to hide or obfuscate results. In that cohort 3 announcement you can read all the highlights at the beginning and have no idea what the actual cohort 3 results were, it's not until the 4th paragraph on the 2nd page that they actually fess up the results which while not exactly bad, were very much sub par compared to cohort 2
They did the same with the ph2 cobra results, the highlights painted a great picture and to be fair it was, but way, way down the announcement somewhere near the end they fess up that it didn't actually meet the endpoints - they should have fessed up at the start of that announcement and then explained why it was still a great result. It's just dishonest reporting and more like what you expect from a penny stock than a quality company. Similarly with releasing trial results in a financial results report or dropping important news during market hours, just not what quality companies generally do. May or may not explain the markets reaction to this, sell first, ask questions later
Whether it was the correction reaction of course we won't know until they fess up the actual results(and even then the overall results are still good), fingers crossed of course that the results are great but I'm wondering if we'll even see them to be honest
When are they doing the 3rd and 4th doses for this cohort? Or has that been canned and not announced? I'd have thought the first 3 patients would have had all 4 doses by now
CU6 Price at posting:
$3.15 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)